February 21, 2013.
Sophia Antipolis, France.
Nicox S.A.(NYSE Euronext Paris: COX) is attending the SECO (South Eastern Congress of Optometry) 2013, taking place from February 27 to March 3 in Atlanta, Georgia, United States (US). Nicox booth number: 241.
Nicox’s US operational team, including Jason Menzo, Director of Marketing, and Mark Puwal, National Director of Sales of Nicox Inc, will present AdenoPlus™, a rapid point-of-care diagnostic test that aids in the differential diagnosis of acute conjunctivitis. AdenoPlus™ was launched by Nicox in the US in October 2012 (see Nicox press release dated October 22, 2012).
“We are thrilled to continue the launch of AdenoPlus™ at this major meeting. Optometry represents a great opportunity for Nicox and our platform of point-of-care diagnostics” said Jerry St. Peter, Executive Vice President and General Manager of Nicox Inc. , the US subsidiary of Nicox S.A.
Nicox’s goal is to become a new international player in the ophthalmic market by building a diversified portfolio of innovative therapies, diagnostic tools and medical devices.